NCT02268890 2016-07-11A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple MyelomaJohnson & Johnson Taiwan LtdPhase 4 Completed18 enrolled
NCT00257114 2008-02-11Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and TolerabilityMillennium Pharmaceuticals, Inc.Phase 4 Completed